*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C531 - Malignant neoplasm of exocervix - as a primary diagnosis code | C531 - Malignant neoplasm of exocervix - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 5.42 | |
| Readmission Rate (%) | 26.14 | |
| Unplanned Readmission Rate (%) | NA | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 755: MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 741: UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 8,709 | |
| Total Hospitalizations with ICD C531 - Malignant neoplasm of exocervix | 11 | |
| DRG Share of Total Hospitalizations | 0.03 | |
| % of Total ICD C531 - Malignant neoplasm of exocervix in DRG | 16.42 | |
| Avg LOS at DRG | 4.65 | |
| Avg LOS with ICD C531 - Malignant neoplasm of exocervix | 3.91 | |
| Readmission Rate at DRG | 31.75 | |
| Readmission Rate with ICD C531 - Malignant neoplasm of exocervix | NA | |
| Unplanned Readmission Rate at DRG | 21.03 | |
| Unplanned Readmission Rate with ICD C531 - Malignant neoplasm of exocervix | NA | |
| Total Medicare payments at DRG | $68,011,869 | |
| Total Medicare payments with ICD C531 - Malignant neoplasm of exocervix | $91,839 | |
| Total Medicare payment per Day at DRG | $1,679 | |
| Total Medicare payment per Day with ICD C531 - Malignant neoplasm of exocervix | $2,136 | |
| Total Medicare payment per Hospitalization at DRG | $7,809 | |
| Total Medicare payment per Hospitalization with ICD C531 - Malignant neoplasm of exocervix | $8,349 | |
| Total Medicare Charges at DRG | $315,355,824 | |
| Total Medicare Charges with ICD C531 - Malignant neoplasm of exocervix | $770,825 | |
| Avg Charges at DRG | $36,210 | |
| Avg Charges with ICD C531 - Malignant neoplasm of exocervix | $70,075 | |
| Mortality Rate at DRG | 4.42 | |
| Mortality Rate with ICD C531 - Malignant neoplasm of exocervix | NA | |
| SNF Discharge Rate at DRG | 10.6 | |
| SNF Discharge Rate with ICD C531 - Malignant neoplasm of exocervix | NA | |
| Home Discharge Rate at DRG | 46.33 | |
| Home Discharge Rate with ICD C531 - Malignant neoplasm of exocervix | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 755: MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 741: UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 8,709 | |
| Total Hospitalizations with ICD C531 - Malignant neoplasm of exocervix | 13 | |
| DRG Share of Total Hospitalizations | 0.03 | |
| % of Total ICD C531 - Malignant neoplasm of exocervix in DRG | 7.88 | |
| Avg LOS at DRG | 4.65 | |
| Avg LOS with ICD C531 - Malignant neoplasm of exocervix | 3.77 | |
| Readmission Rate at DRG | 31.75 | |
| Readmission Rate with ICD C531 - Malignant neoplasm of exocervix | NA | |
| Unplanned Readmission Rate at DRG | 21.03 | |
| Unplanned Readmission Rate with ICD C531 - Malignant neoplasm of exocervix | NA | |
| Total Medicare payments at DRG | $68,011,869 | |
| Total Medicare payments with ICD C531 - Malignant neoplasm of exocervix | $106,905 | |
| Total Medicare payment per Day at DRG | $1,679 | |
| Total Medicare payment per Day with ICD C531 - Malignant neoplasm of exocervix | $2,182 | |
| Total Medicare payment per Hospitalization at DRG | $7,809 | |
| Total Medicare payment per Hospitalization with ICD C531 - Malignant neoplasm of exocervix | $8,223 | |
| Total Medicare Charges at DRG | $315,355,824 | |
| Total Medicare Charges with ICD C531 - Malignant neoplasm of exocervix | $838,100 | |
| Avg Charges at DRG | $36,210 | |
| Avg Charges with ICD C531 - Malignant neoplasm of exocervix | $64,469 | |
| Mortality Rate at DRG | 4.42 | |
| Mortality Rate with ICD C531 - Malignant neoplasm of exocervix | NA | |
| SNF Discharge Rate at DRG | 10.6 | |
| SNF Discharge Rate with ICD C531 - Malignant neoplasm of exocervix | NA | |
| Home Discharge Rate at DRG | 46.33 | |
| Home Discharge Rate with ICD C531 - Malignant neoplasm of exocervix | NA |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 13 |